SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-05-000419
Filing Date
2005-12-09
Accepted
2005-12-09 17:28:51
Documents
8
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a15269e10vq.htm 10-Q 553511
2 EXHIBIT 10.283 a15269exv10w283.txt EX-10.283 3099
3 EXHIBIT 10.284 a15269exv10w284.txt EX-10.284 28985
4 EXHIBIT 10.285 a15269exv10w285.txt EX-10.285 47579
5 EXHIBIT 31.1 a15269exv31w1.htm EX-31.1 6456
6 EXHIBIT 31.2 a15269exv31w2.htm EX-31.2 6448
7 EXHIBIT 32.1 a15269exv32w1.htm EX-32.1 4239
8 EXHIBIT 32.2 a15269exv32w2.htm EX-32.2 4232
  Complete submission text file 0000936392-05-000419.txt   655975
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 051256581
SIC: 2834 Pharmaceutical Preparations